Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
1972
-
Total 13F shares, excl. options
-
2.02B
-
Shares change
-
-18.4M
-
Total reported value, excl. options
-
$113B
-
Value change
-
-$1.11B
-
Put/Call ratio
-
1.24
-
Number of buys
-
807
-
Number of sells
-
-929
-
Price
-
$56.27
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q4 2017
2,172 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q4 2017.
Merck & Co., Inc. - Common Stock (MRK) has 1,972 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.02B shares
of 2.53B outstanding shares and own 79.74% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (197M shares), BlackRock Inc. (185M shares), STATE STREET CORP (118M shares), WELLINGTON MANAGEMENT GROUP LLP (94.1M shares), Capital World Investors (89.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (54.2M shares), FRANKLIN RESOURCES INC (43.2M shares), NORTHERN TRUST CORP (35.6M shares), Bank of New York Mellon Corp (35.3M shares), and JPMORGAN CHASE & CO (33.5M shares).
This table shows the top 1972 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.